Identifying new ligands for the SARS-CoV-2 Macrodomain by Fragment Screening and Multi-temperature Crystallography
Description
Macrodomain is a compelling target for SARS-CoV-2, but there are no inhibitors (or even starting points for inhibitors). The QCRG Structural Biology Consortium performed a crystallographic fragments screen, identifying a few small molecules to kick-start our work to develop an inhibitor. Our friends in the UK, Ivan Ahel’s lab and X-Chem, did something similar and found even more fragment starting points. We are releasing the data together!
This record has the data available here: https://fraserlab.com/macrodomain/ prior to public release on July 9, 2020.
Files
hits_mtzs_models.zip
Additional details
Related works
- Is derived from
- https://fraserlab.com/macrodomain/ (URL)
- https://github.com/fraser-lab/fraser-lab.github.io/tree/master/macrodomain (URL)